| Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial CL Raison, G Sanacora, J Woolley, K Heinzerling, BW Dunlop, RT Brown, ... Jama 330 (9), 843-853, 2023 | 247 | 2023 |
| Psilocybin-assisted therapy of major depressive disorder using acceptance and commitment therapy as a therapeutic frame J Sloshower, J Guss, R Krause, RM Wallace, MT Williams, S Reed, ... Journal of Contextual Behavioral Science 15, 12-19, 2020 | 162 | 2020 |
| Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial J Sloshower, PD Skosnik, H Safi-Aghdam, S Pathania, S Syed, B Pittman, ... Journal of Psychopharmacology 37 (7), 698-706, 2023 | 85 | 2023 |
| The Yale manual for psilocybin-assisted therapy of depression (using acceptance and commitment therapy as a therapeutic frame) J Guss, R Krause, J Sloshower PsyArXiv, 2020 | 68 | 2020 |
| Research abuses against people of colour and other vulnerable groups in early psychedelic research D Strauss, S de la Salle, J Sloshower, MT Williams Journal of Medical Ethics 48 (10), 728-737, 2022 | 46 | 2022 |
| Neuroendocrine associations underlying the persistent therapeutic effects of classic serotonergic psychedelics EAD Schindler, RM Wallace, JA Sloshower, DC D’Souza Frontiers in pharmacology 9, 177, 2018 | 46 | 2018 |
| Describing the content of primary care: limitations of Canadian billing data A Katz, G Halas, M Dillon, J Sloshower BMC Family Practice 13, 1-5, 2012 | 37 | 2012 |
| Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms PD Skosnik, J Sloshower, H Safi-Aghdam, S Pathania, S Syed, B Pittman, ... Journal of Psychopharmacology 37 (7), 687-697, 2023 | 32 | 2023 |
| Online sales of unscheduled pharmaceutical agents: a case report of tianeptine use in the United States S Gupta, R Wallace, J Sloshower Journal of Addiction Medicine 11 (5), 411-412, 2017 | 22 | 2017 |
| Integrating psychedelic medicines and psychiatry: theory and methods of a model clinic J Sloshower Plant medicines, healing and psychedelic science: Cultural perspectives, 113-132, 2018 | 20 | 2018 |
| Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial J Sloshower, RJ Zeifman, J Guss, R Krause, H Safi-Aghdam, S Pathania, ... Scientific Reports 14 (1), 8833, 2024 | 13 | 2024 |
| Psychedelic medicine: Creating an introductory course for mental health professionals and trainees WL Prueitt, J Sloshower Academic Psychiatry 47 (1), 74-77, 2023 | 7 | 2023 |
| The Yale manual for psilocybin-assisted therapy of depression J Sloshower, J Guss, R Krause doi 10, 207-215, 2020 | 3 | 2020 |
| Capturing suffering: Ethical considerations of bearing witness and the use of photography J Sloshower The International Journal of the Image 3 (2), 11, 2013 | 2 | 2013 |
| Navigating the mainstreaming of psychedelics BC Labate, HF Antunes, J Beachy, J Sloshower, C Cavnar Journal of Psychedelic Studies, 2025 | | 2025 |
| A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research DB Yaden, M Graziosi, AM Owen, G Agin-Liebes, ST Aaronson, KE Allen, ... Psychedelic Medicine, 2025 | | 2025 |
| O relatório da DEA sobre os riscos da ayahuasca: a “ciência” a serviço do proibicionismo? HF Antunes, BC Labate, A Ermakova, J Sloshower, N Galvão-Coelho, ... Ponto Urbe 32 (2), e225852-e225852, 2024 | | 2024 |
| The DEA report on ayahuasca risks:“Science” in service of prohibition? B Labate, AO Ermakova, J Sloshower, N Galvão-Coelho, ... Journal of Psychedelic Studies 7 (2), 81-89, 2023 | | 2023 |
| Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine J Guss, R Krause, J Sloshower PsyArXiv, 2022 | | 2022 |
| Psychedelic Medicine: Past, Present, Future (elective course syllabus) W Prueitt, J Sloshower PsyArXiv, 2020 | | 2020 |